The study's primary endpoint is to demonstrate an ORR benefit compared to historical control of 12-15%.
Twenty-four patients will be enrolled under the first phase of the VAL-083 REPROVe Trial with top line results expected within 18-24 months from trial initiation of patient treatment.
Chat Random is over 200,000 users and 21 billion connections strong -- and counting.
An inspired Chatroulette alternative, Chat Random delivers a safer, simpler platform for random video chatting with strangers in a multi-dimensional format.
Users must be 18 , and the site upholds its user terms of service by employing full-time monitors who swiftly shut down illegal activity or usage by minors.
Del Mar has demonstrated that VAL-083's mechanism of action is distinct from multiple chemotherapies widely used in the treatment of cancer and that this unique mechanism may offer opportunities to overcome treatment resistance thereby offering new treatment options to cancer patients.
Further details regarding these studies can be found at Del Mar Pharmaceuticals is focused on the development and commercialization of new therapies for cancer patients who have limited or no treatment options. Based on Del Mar's internal research programs and these prior NCI-sponsored clinical studies, the Company is conducting clinical trials to support the development and commercialization of VAL-083 across multiple oncology indications to solve significant unmet medical needs.